Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human dyskerin

EU orphan designation number: EU/3/12/1070   
Active ingredient: Recombinant human dyskerin
Indication: Treatment of dyskeratosis congenita
Sponsor: Advanced Medical Projects
Edificio TecnoAlcalá, Av. Punto Com 2, Campus Universitario, Alcalá de Henares, E-28805 Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Centralised Orphan - Designation EMA/OD/136/11 (2012)8207 of 08/11/2012